1-27100489-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_003047.5(SLC9A1):c.2266G>A(p.Glu756Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E756Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_003047.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC9A1 | NM_003047.5 | c.2266G>A | p.Glu756Lys | missense_variant | 12/12 | ENST00000263980.8 | NP_003038.2 | |
SLC9A1 | XM_011542021.4 | c.1936G>A | p.Glu646Lys | missense_variant | 13/13 | XP_011540323.1 | ||
SLC9A1 | XM_047428769.1 | c.1936G>A | p.Glu646Lys | missense_variant | 16/16 | XP_047284725.1 | ||
SLC9A1 | NR_046474.2 | n.2596G>A | non_coding_transcript_exon_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC9A1 | ENST00000263980.8 | c.2266G>A | p.Glu756Lys | missense_variant | 12/12 | 1 | NM_003047.5 | ENSP00000263980.3 | ||
SLC9A1 | ENST00000374089.5 | n.1491G>A | non_coding_transcript_exon_variant | 7/7 | 2 | |||||
SLC9A1 | ENST00000447808.1 | n.743G>A | non_coding_transcript_exon_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251414Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135872
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461812Hom.: 0 Cov.: 38 AF XY: 0.0000509 AC XY: 37AN XY: 727220
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.2266G>A (p.E756K) alteration is located in exon 12 (coding exon 12) of the SLC9A1 gene. This alteration results from a G to A substitution at nucleotide position 2266, causing the glutamic acid (E) at amino acid position 756 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1933229). This variant has not been reported in the literature in individuals affected with SLC9A1-related conditions. This variant is present in population databases (rs778021539, gnomAD 0.004%). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 756 of the SLC9A1 protein (p.Glu756Lys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at